Fifty-one Kaposi sarcoma patients

Area of Science:

• Oncology
• Dermatology
• Pathology

Background:

• Kaposi sarcoma (KS) is a mesenchymal tumor linked to lymphatic endothelial cells.
• Immunosuppression and human herpesvirus 8 (HHV-8) are key risk factors in KS development.
• Understanding KS demographics, characteristics, and treatments is crucial for patient management.

Purpose of the Study:

• To evaluate the demographic properties of Kaposi sarcoma (KS) patients.
• To analyze tumor characteristics and their correlation with patient demographics.
• To assess various treatment modalities employed for Kaposi sarcoma.

Main Methods:

• Retrospective analysis of histopathologically confirmed Kaposi sarcoma (KS) cases.
• Evaluation of patient demographics, tumor site, diagnostic procedures, and treatment regimens.
• Assessment of anti-HIV seroprevalence alongside patient and tumor characteristics.

Main Results:

• The study included 51 KS patients (male/female ratio 3.25:1), with a median age of 68 years.
• Lower extremity was the most common tumor site; radiotherapy was the most frequent local monotherapy (26%).
• A multidisciplinary approach was used in 44% of cases, with radiotherapy often combined with surgery; chemotherapy (12%) and interferon (6%) were less common.

Conclusions:

• Male patients in their sixth decade represent a higher-risk group for Kaposi sarcoma (KS).
• Smoking is prevalent among KS patients (42.8%), highlighting its potential role.
• While local therapies are effective for many, systemic chemotherapy regimens like vincristine, bleomycin, and doxorubicin are options for selected KS patients.